David Crispino Volpe, Chief Financial Officer at AdvanSource Biomaterials Corp (ASNB), bought 10,000 shares at $0.06 ($600) on 2013-08-29, disclosed to the SEC on 2013-09-03.
Open-market purchase of $600 ASNB by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ASNB | BUY | 2012-12-04 | $150 | — | Filing → |
| ASNB | BUY | 2012-12-03 | $200 | — | Filing → |
| ASNB | BUY | 2012-11-21 | $1K | — | Filing → |